Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441701
Status:
TERMINATED
Last Update Posted:
2019-01-02
First Post:
2007-02-28
Brief Title:
Study to Evaluate the Safety and Dose-Range of Navarixin SCH 527123 MK-7123 in Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease COPD MK-7123-012
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2008-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-28
First Submit QC Date:
February 28 2007
Study First Post Date:
2007-03-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-09-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-10
Last Update Post Date:
2019-01-02
Last Update Post Date Type:
ACTUAL